Regorafenib Clinical Trials
22 recruitingDrug
Phase 219Phase 33Phase 12
Showing 1–20 of 22 trials
Recruiting
Phase 2Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Glioblastoma
Global Coalition for Adaptive Research2,250 enrolled63 locationsNCT03970447
Recruiting
Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Advanced Solid TumorsMultiple MyelomaLymphoma, Non-Hodgkin
American Society of Clinical Oncology4,200 enrolled174 locationsNCT02693535
Recruiting
Phase 2
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
University of Miami30 enrolled1 locationNCT06902246
Recruiting
Phase 1Phase 2
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Cervical CancerBrain Metastases, AdultDiffuse Astrocytoma, IDH-Mutant+1 more
Neonc Technologies, Inc.134 enrolled6 locationsNCT06047379
Recruiting
Phase 2
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
Malignant Solid Tumor
Centre Leon Berard455 enrolled10 locationsNCT04116541
Recruiting
Phase 2
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Gastrointestinal Stromal Tumors
University of Miami48 enrolled1 locationNCT05366816
Recruiting
Phase 2
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Ovarian CancerSerous Ovarian Cancer
Sarah K. Lynam MD31 enrolled1 locationNCT05113368
Recruiting
Phase 2
Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
Hepatocellular Carcinoma (HCC)
Fudan University141 enrolled1 locationNCT07100392
Recruiting
Phase 2
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Hepatocellular Carcinoma
Humanity & Health Medical Group Limited30 enrolled1 locationNCT03899428
Recruiting
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD300 enrolled2 locationsNCT05713994
Recruiting
Phase 2
Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis
Liver MetastasesColorectal Cancer Metastatic
Fudan University25 enrolled1 locationNCT05057052
Recruiting
Phase 2Phase 3
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon446 enrolled16 locationsNCT05462613
Recruiting
Phase 2
Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Metastatic Colorectal Cancer
Centre Hospitalier Universitaire de Besancon174 enrolled10 locationsNCT06425133
Recruiting
Phase 2
Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
Fudan University108 enrolled1 locationNCT05963490
Recruiting
Phase 2
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
CRC
Jin-hong Chen44 enrolled3 locationsNCT06455254
Recruiting
Phase 2
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
Advanced CancerSolid TumorHaematological Malignancy
Helsinki University Central Hospital250 enrolled5 locationsNCT05159245
Recruiting
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital300 enrolled4 locationsNCT05717738
Recruiting
Phase 1Phase 2
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Rhabdomyosarcoma
University of Birmingham1,672 enrolled128 locationsNCT04625907
Recruiting
Phase 2
The Drug Rediscovery Protocol (DRUP Trial)
CancerNeoplasmNeoplasia+1 more
The Netherlands Cancer Institute1,550 enrolled36 locationsNCT02925234
Recruiting
Phase 2
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
Digestive System Cancers
Peking University Cancer Hospital & Institute39 enrolled1 locationNCT06099821